Rajapakse Senaka, Rodrigo Chaturaka, Rajapakse Anoja, Kirthinanda Dinoo, Wijeratne Sujani
Faculty of Medicine, University of Colombo, Sri Lanka.
Saudi J Kidney Dis Transpl. 2009 Jul;20(4):553-9.
Acute renal failure (ARF) is a common complication of sepsis and carries a high mortality. Renal replacement therapy (RRT) during the acute stage is the mainstay of therapy. Va-rious modalities of RRT are available. Continuous RRT using convective methods are preferred in sepsis-induced ARF, especially in hemodynamically unstable patients, although clear evidence of benefit over intermittent hemodialysis is still not available. Peritoneal dialysis is clearly inferior, and is not recommended. Early initiation of RRT is probably advantageous, although the optimal timing of dialysis is yet unknown. Higher doses of RRT are more likely to be beneficial. Use of bio-compatible membranes and bicarbonate buffer in the dialysate are preferred. Anticoagulation during dialysis must be carefully adjusted and monitored.
急性肾衰竭(ARF)是脓毒症的常见并发症,死亡率很高。急性期的肾脏替代治疗(RRT)是主要的治疗方法。有多种RRT方式可供选择。在脓毒症诱发的ARF中,尤其是血流动力学不稳定的患者,采用对流方法的连续性RRT是首选,尽管与间歇性血液透析相比,其益处仍缺乏明确证据。腹膜透析明显较差,不建议使用。尽早开始RRT可能有益,尽管透析的最佳时机尚不清楚。更高剂量的RRT更可能有益。透析液中使用生物相容性膜和碳酸氢盐缓冲液更佳。透析期间的抗凝必须仔细调整和监测。